22 October 2026 • From the 20 October 2026 brief • 6 min read
A managed-care startup that began as a membership app is spending a $50 Mn Series B on hospitals, and reports readmissions below 1% against an industry range of 8-15%: in care delivery, outcomes are the product metric and owning capacity is the moat.
Even Healthcare, the Bengaluru managed-care company, has raised $50 Mn (about ₹475 Cr) in an all-equity Series B led by existing investor Khosla Ventures with Alpha Wave participating. Total funding is now over $120 Mn; the company raised $20 Mn earlier this year, and Inc42 reports the valuation has tripled since the previous round 18 months ago. The figure itself was not disclosed.
The money goes into buildings. Even runs two multispeciality hospitals in Bengaluru, on Race Course Road and in HBR Layout. It plans a third by the end of 2026 and three more by the end of FY27, and only then other cities. It says it has more than 2.5 Lakh members across 10 cities, that membership tripled in a year, and that 85-90% of members who live near a Bengaluru hospital choose Even when they need care.
Two other facts frame the raise. Even reports unplanned re-admissions below 1% in its insurance-partner programmes, against an industry range of 8-15%, hospital stays 40% shorter, and over 200 members kept out of hospital at an estimated saving of ₹15 Cr to ₹16 Cr. And in August it laid off around 350 people, 30-35% of its workforce. The capital is going to beds and clinicians, not to headcount in the app.
Reported by Inc42; carried as story 1 in our 20 October 2026 brief.
| What | Figure | Where it comes from |
|---|---|---|
| Series B | $50 Mn (about ₹475 Cr), all equity; Khosla Ventures lead, Alpha Wave | Inc42, 19 Oct 2026 |
| Total funding | Over $120 Mn; $20 Mn raised earlier this year | Inc42, 19 Oct 2026 |
| Hospitals | 2 now (Bengaluru); 1 more by end 2026, 3 more by end FY27 | Inc42, 19 Oct 2026 |
| Members | More than 2.5 Lakh across 10 cities; tripled in a year | Inc42, 19 Oct 2026 (company claim) |
| Outcomes claimed | Re-admissions below 1% in insurance-partner programmes vs 8-15% industry; stays 40% shorter; 200+ hospitalisations avoided, ₹15-16 Cr saved | Inc42, 19 Oct 2026 (company claim) |
| Layoffs | Around 350 people in August, 30-35% of staff | Inc42, 19 Oct 2026 |
Even started as a membership and care-coordination product and is now spending a $50 Mn round on four hospitals. The reason is in its own numbers: 85-90% of members near a hospital choose it, so every hospital it owns turns nearby members into care it runs end to end. If you build healthtech software and will never own beds, the Arjun and Meera point from the brief applies: decide which parts of the care pathway you can own (triage, follow-up, pharmacy, diagnostics booking) and make the integration with hospitals that do own beds the thing nobody else can replicate.
The figures that justify this raise are clinical and financial outcomes: re-admissions below 1% in insurance-partner programmes against 8-15%, stays 40% shorter, over 200 members kept out of hospital and ₹15 Cr to ₹16 Cr saved. None of those is an engagement metric. A healthtech product that reports daily active users and retention curves is measuring the wrong thing for its buyers (insurers, employers, hospital groups). Add outcome events to your analytics now, with the clinician's definition of each, so that in 18 months you have a year of data rather than a claim.
Even cut around 350 people, 30-35% of its workforce, two months before raising $50 Mn for hospitals. That is a statement about where the next rupee of value is: in beds, doctors and nurses, not in a larger app team. If you are a product manager or engineer in a care-delivery company, the roles that survive are the ones tied to clinical throughput and outcomes (scheduling, follow-up automation, claims, documentation). If you sell software to such companies, price it against the cost of a clinician's hour, which is the budget it will be compared with.
Two multispeciality hospitals in Bengaluru, on Race Course Road and in HBR Layout, as of October 2026. It plans a third by the end of 2026 and three more by the end of FY27, then other cities.
No. The re-admission rate below 1%, the 40% shorter stays and the ₹15 Cr to ₹16 Cr saved are the company's claims as reported by Inc42. Treat them as the metrics Even chose to be judged on, not as audited figures.
Pick the pathway steps you can own and make your hospital integrations hard to replace. Measure outcomes, not engagement, because that is what employers, insurers and this round's investors are paying for.
This page is written from one story in the daily brief. Nine stories, every morning at 09:15 IST.
Get the brief free →